Literature DB >> 14819282

Use of radiophosphorus in studies of glomerular permeability of plasma inorganic phosphate.

P HANDLER, D V COHN.   

Abstract

Entities:  

Keywords:  BLOOD PLASMA; KIDNEYS; PHOSPHATES; PHOSPHORUS AND COMPOUNDS, RADIOACTIVE

Mesh：

Substances：

Year:  1951        PMID： 14819282     DOI： 10.1152/ajplegacy.1951.164.3.646

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  8 in total

1.  [RESEARCH ON RENAL PHOSPHATE EXCRETION IN PATIENTS WITH VARIOUS NEPHROPATHIES WITH PARTICULAR CONSIDERATION OF PATIENTS WITH PRIMARY HYPERPARATHYROIDISM].

Authors:  H D HORN; H NIETH; G GROTE
Journal:  Klin Wochenschr       Date:  1964-10-15

2.  Protein-binding of inorganic phosphate in plasma of normal subjects and patients with renal disease.

Authors:  M WALSER
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

3.  [Research on renal phosphate excretion in man with carrier-free P 32].

Authors:  S HELLER; G HILLMANN
Journal:  Klin Wochenschr       Date:  1961-03-01

4.  [Hyperphosphatemia as a symptom of tubular insufficiency].

Authors:  F LINNEWEH; U STAVE
Journal:  Klin Wochenschr       Date:  1956-10-01

5.  Phosphorus excretion in renal failure.

Authors:  R GOLDMAN; S H BASSETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

6.  [Tubular secretion of phosphate; excretion of organic and inorganic phosphate in cat].

Authors:  R TAUGNER; M VON RUBNOFF; W BRAUN
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1953

7.  Movement of [14C]bicarbonate from blood to cerebrospinal fluid and brain.

Authors:  R V Coxon; A G Swanson
Journal:  J Physiol       Date:  1965-12       Impact factor: 5.182

8.  Estimation of the phospholipid phosphorus turnover time in man: studies in normal individuals, in patients with the nephrotic syndrome and in other types of hyperlipemia.

Authors:  H W MOSER; K EMERSON
Journal:  J Clin Invest       Date:  1955-08       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.